Start with intended use
The control strategy begins with the process, decision, data and potential impact—not the novelty of the technology.
Consulting
GxP Frame helps pharmaceutical, biotechnology, medical-device, CRO and CDMO teams govern, qualify and sustain AI-enabled work. Engagements can strengthen an existing implementation, establish a defensible path to production, qualify the people using the system or recover a program whose controls have not kept pace with adoption.
The control strategy begins with the process, decision, data and potential impact—not the novelty of the technology.
Requirements, risks, tests, decisions, exceptions and changes should form a coherent record that another qualified person can evaluate.
Technology, suppliers, procedures, data, people and oversight must work together. A technically capable model is only one component.
Consulting services
Scope is tailored to the system's intended use, maturity, risk and regulated context. The work can address one urgent control gap or establish an end-to-end operating model.
01
An independent review of the intended use, regulated-process impact, current controls and retained evidence around an AI-enabled system already in use or approaching production.
02
A risk-based qualification strategy tied to what the system is intended to do, the decisions it influences and the records or processes it can affect.
03
Role-specific qualification that tests whether people can operate the system within approved boundaries—not merely whether they completed training.
04
Practical governance that connects policy to ownership, evidence, decision rights and day-to-day execution across Quality, business, technology and data teams.
05
Due diligence focused on whether a supplier's capabilities, controls and evidence are adequate for the proposed regulated use—not on generic feature claims.
06
Focused support when AI-enabled work must be made reviewable, when controls have drifted, or when an audit, deviation or inspection exposes a weakness.
Typical deliverables
Every engagement has a written scope and acceptance criteria. Depending on the need, the resulting package may include the following.
Ways to engage
The engagement model follows the decision the organization needs to make and the capability it needs to retain afterward.
A defined review of one system, use case or program, ending with prioritized findings, decision points and a practical remediation sequence.
Embedded support through design, supplier selection, qualification, controlled launch and transfer into routine operations.
A time-bounded intervention to restore control, reconstruct evidence, resolve findings and establish a maintainable operating state.
Ongoing senior support for organizations that need accountable program direction without adding a permanent specialist role immediately.
Experience behind the work
Engagements are led by Brian J. Drapeau, founder and principal consultant of GxP Frame. His experience spans cell and gene therapy manufacturing, GxP training governance, inspection readiness, LMS and QMS implementation, role qualification and the practical governance of AI-assisted work. That operating background keeps recommendations tied to how regulated work is approved, performed, evidenced and sustained.
Review experience and credentialsStart with the decision
The initial conversation identifies the use case, regulated context, current state, immediate decision and information restrictions before a scope is proposed.